0001942459-24-000007.txt : 20240307
0001942459-24-000007.hdr.sgml : 20240307
20240307173635
ACCESSION NUMBER: 0001942459-24-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240305
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bornstein Jonathan
CENTRAL INDEX KEY: 0001942459
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41314
FILM NUMBER: 24731500
MAIL ADDRESS:
STREET 1: 1180 PAGE AVENUE
CITY: FREMONT
STATE: CA
ZIP: 94538
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amprius Technologies, Inc.
CENTRAL INDEX KEY: 0001899287
STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
ORGANIZATION NAME: 04 Manufacturing
IRS NUMBER: 981591811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1180 PAGE AVENUE
CITY: FREMONT
STATE: CA
ZIP: 94538
BUSINESS PHONE: (800) 425-8803
MAIL ADDRESS:
STREET 1: 1180 PAGE AVENUE
CITY: FREMONT
STATE: CA
ZIP: 94538
FORMER COMPANY:
FORMER CONFORMED NAME: Kensington Capital Acquisition Corp. IV
DATE OF NAME CHANGE: 20211214
4
1
wk-form4_1709850983.xml
FORM 4
X0508
4
2024-03-05
0
0001899287
Amprius Technologies, Inc.
AMPX
0001942459
Bornstein Jonathan
C/O AMPRIUS TECNOLOGIES, INC.,
1180 PAGE AVENUE
FREMONT
CA
94538
0
1
0
0
President of Amprius Lab
1
Common stock
2024-03-05
4
M
0
109800
0.05
A
109800
D
Common stock
2024-03-05
4
S
0
109800
2.9186
D
0
D
Common stock
2024-03-06
4
M
0
40200
0.05
A
40200
D
Common stock
2024-03-06
4
S
0
40200
2.7756
D
0
D
Stock Option (right to buy)
0.05
2024-03-05
4
M
0
109800
0
D
2022-09-14
2027-03-15
Common stock
109800
1174051
D
Stock Option (right to buy)
0.05
2024-03-06
4
M
0
40200
0
D
2022-09-14
2027-03-15
Common stock
40200
1133851
D
The exercises and sales reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2023.
The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $2.87 to $3, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $2.72 to $2.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
/s/ Sandra Wallach, attorney-in-fact on behalf of Jonathan Bornstein
2024-03-07